238 related articles for article (PubMed ID: 24377379)
1. Diagnostic procedures in vitreoretinal lymphoma.
Dalal M; Casady M; Moriarty E; Faia L; Nussenblatt R; Chan CC; Sen HN
Ocul Immunol Inflamm; 2014 Aug; 22(4):270-6. PubMed ID: 24377379
[TBL] [Abstract][Full Text] [Related]
2. More than a masquerade syndrome: atypical presentations of vitreoretinal lymphomas.
AlQahtani A; Touitou V; Cassoux N; Aknin C; Merle-Beral H; Bodaghi B; LeHoang P
Ocul Immunol Inflamm; 2014 Jun; 22(3):189-96. PubMed ID: 24475870
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome.
Coupland SE; Bechrakis NE; Anastassiou G; Foerster AM; Heiligenhaus A; Pleyer U; Hummel M; Stein H
Graefes Arch Clin Exp Ophthalmol; 2003 Oct; 241(10):860-70. PubMed ID: 14605902
[TBL] [Abstract][Full Text] [Related]
4. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
[TBL] [Abstract][Full Text] [Related]
5. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
6. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
Levasseur SD; Wittenberg LA; White VA
JAMA Ophthalmol; 2013 Jan; 131(1):50-5. PubMed ID: 23307208
[TBL] [Abstract][Full Text] [Related]
7. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma.
Ito T; Takeda A; Fujiwara K; Hasegawa E; Nakao S; Ohishi Y; Oda Y; Yoshikawa H; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):1029-1036. PubMed ID: 30868235
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.
Rajagopal R; Harbour JW
Retina; 2011 Mar; 31(3):435-40. PubMed ID: 21336066
[TBL] [Abstract][Full Text] [Related]
10. Primary Vitreoretinal Lymphoma Presenting as a Posterior Capsule Plaque.
Hussain RM; Garoon RB; Duker JS; Dubovy SR; Albini TA
Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):732-734. PubMed ID: 30222812
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic efficacy of cell block method for vitreoretinal lymphoma.
Kase S; Namba K; Iwata D; Mizuuchi K; Kitaichi N; Tagawa Y; Okada-Kanno H; Matsuno Y; Ishida S
Diagn Pathol; 2016 Mar; 11():29. PubMed ID: 26987877
[TBL] [Abstract][Full Text] [Related]
12. DIAGNOSTIC YIELD OF IN VITRO VITREOUS BIOPSY FOR INTRAOCULAR LYMPHOMA AT VARIABLE VITREOUS CUTTER SPEEDS USING 25-GAUGE VITRECTOMY.
Tekumalla S; Xu D; Awh K; Philp N; Milman T; Garg S
Retina; 2023 Jun; 43(6):1005-1009. PubMed ID: 36735414
[TBL] [Abstract][Full Text] [Related]
13. Perivascular tumour balls in primary vitreoretinal lymphoma.
Takkar B; Rathi A; Gaur N; Kumar A
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567275
[No Abstract] [Full Text] [Related]
14. Aqueous Humor-Derived MYD88 L265P Mutation Analysis in Vitreoretinal Lymphoma: A Potential Less Invasive Method for Diagnosis and Treatment Response Assessment.
Demirci H; Rao RC; Elner VM; Demirci FY; Axenov L; Betz B; Behdad A; Brown N
Ophthalmol Retina; 2023 Feb; 7(2):189-195. PubMed ID: 35952929
[TBL] [Abstract][Full Text] [Related]
15. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic testing of vitrectomy specimens.
Davis JL; Miller DM; Ruiz P
Am J Ophthalmol; 2005 Nov; 140(5):822-829. PubMed ID: 16310459
[TBL] [Abstract][Full Text] [Related]
17. Relationship between suspected reasons of intraocular inflammation and the results of diagnostic vitrectomy: an observational study.
Kitiratschky VB; Deuter C; Beck R; Schulte B; Müller H; Blumenstock G; Szurman P
Ocul Immunol Inflamm; 2015 Feb; 23(1):59-66. PubMed ID: 24392961
[TBL] [Abstract][Full Text] [Related]
18. DEVELOPMENT OF EPSTEIN-BARR VIRUS UVEITIS AFTER REMISSION OF PRIMARY VITREORETINAL LYMPHOMA.
Chahal BS; Rasmussen S; White VA; Forooghian F
Retin Cases Brief Rep; 2016; 10(2):131-3. PubMed ID: 26267526
[TBL] [Abstract][Full Text] [Related]
19. Acquired drusenoid deposits on infrared imaging as a sign of vitreoretinal lymphoma.
Campbell JP; Davis S; Flaxel C; Rosenbaum JT; Lin P
Ocul Immunol Inflamm; 2014 Apr; 22(2):161-3. PubMed ID: 24063755
[No Abstract] [Full Text] [Related]
20. Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.
Kwak JJ; Lee KS; Lee J; Kim YJ; Choi EY; Byeon SH; Chang WS; Kim YR; Kim JS; Shin S; Lee ST; Kim SS; Lee CS
Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):27. PubMed ID: 37975847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
